Multiple sclerosis Trials in Philadelphia, United States
Conditions / Multiple sclerosis / Philadelphia, United States
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
70 total trials for this combination
Showing top 10 of 70 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00355134 | Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT06141473 | Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis | RECRUITING | PHASE3 |
| NCT02047097 | Dimethyl Fumarate (DMF) Observational Study | COMPLETED | — |
| NCT01707992 | The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE3 |
| NCT06141486 | Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis | RECRUITING | PHASE3 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT01442194 | Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies | COMPLETED | — |
| NCT03886753 | Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products | TERMINATED | — |
| NCT05162638 | Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation | ENROLLING_BY_INVITATION | NA |
| NCT00751881 | An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |